文献速递肥胖与代谢综合征性腺与生殖内分泌

GLP1激动剂对生殖功能的影响

Effect of GLP1 Agonists on Reproduction.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

肥胖与男女生殖功能障碍相关,减重可改善生殖功能。临床前研究显示GLP1激动剂可能直接作用于下丘脑促LH分泌,并对性腺和子宫内膜有益。但人类中是否有超越减重的直接获益尚不明确,且孕期减重与胎儿不良结局相关,临床前研究提示该类药物有胎儿毒性,需谨慎使用。

要点

  • 肥胖相关生殖功能障碍患者减重可改善生殖功能,GLP1激动剂是可选减重手段。
  • 临床前证据提示GLP1激动剂可能直接刺激下丘脑LH分泌并有益于性腺和子宫内膜。
  • 人类中GLP1激动剂对生殖器官的直接获益尚不明确,需权衡胎儿毒性风险。

核心结论

  • 动物和人类数据表明减重可改善生殖功能,无论是否使用GLP1激动剂。
  • 临床前研究提示GLP1激动剂可能直接刺激下丘脑LH分泌并对性腺和子宫内膜有益。
  • 人类中GLP1激动剂是否提供超越减重的直接生殖获益尚不清楚。
  • 考虑用GLP1激动剂治疗肥胖相关生殖功能障碍需谨慎,因孕期任何减重与胎儿不良结局相关,且临床前研究提示该类药物有胎儿毒性。

研究设计与样本

  • 综述,汇总临床前和临床证据,评估GLP1激动剂对人类生殖健康的影响。

主要发现

  • 肥胖在动物和人类中与男女生殖功能障碍相关。
  • 减重(伴或不伴GLP1激动剂)可改善动物和人类的生殖功能。
  • 临床前研究显示GLP1激动剂直接作用于下丘脑刺激LH分泌,并对性腺和子宫内膜有直接有益效应。

临床怎么用

  • GLP1激动剂可用于肥胖相关生殖功能障碍患者的减重治疗,但需谨慎评估。
  • 应避免孕期使用GLP1激动剂,因孕期减重与胎儿不良结局相关且临床前提示胎儿毒性。

局限性

  • 人类中GLP1激动剂对生殖器官的直接获益是否超越减重尚不明确。
  • 需要未来研究进一步明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Obesity, in animals and humans, is associated with male and female reproductive dysfunction. Elucidating the mechanisms by which excessive weight affects reproduction and proving that weight loss improves reproductive function has been difficult. Data in animals and humans demonstrate improvements in reproductive function after weight loss, achieved with or without glucagon-like peptide 1 (GLP1) agonists. In preclinical studies there is evidence that GLP1 agonists have direct effects on the hypothalamus to stimulate luteinizing hormone (LH) secretion and direct beneficial effects on the gonads and the endometrium. Whether GLP-1 agonists provide an added direct beneficial effect on reproductive organs in humans, beyond the benefits mediated by weight loss, remains unclear. However, consideration of GLP1 agonists for the treatment for obesity-associated reproductive dysfunction requires caution, as any weight loss during pregnancy is associated with adverse fetal outcomes, and preclinical studies indicate fetal toxicity of the GLP1 agonist class. Here, we review the available preclinical and clinical evidence of the effects of GLP-1 agonists on human reproductive health, suggest a therapeutic strategy, and list the needs for future research.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Couldwell M, Tidwell AJ, Taylor AE, et al. Effect of GLP1 Agonists on Reproduction. J Clin Endocrinol Metab. 2025. PMID: 40658801. doi:10.1210/clinem/dgaf401

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。